Julia Irena Paczkowska, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hodgkin Disease | 4 | 2023 | 1378 | 1.340 |
Why?
|
| MicroRNAs | 6 | 2023 | 3816 | 0.830 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2020 | 1062 | 0.550 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 736 | 0.400 |
Why?
|
| Gene Deletion | 1 | 2019 | 2665 | 0.370 |
Why?
|
| DNA Methylation | 6 | 2021 | 4398 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-maf | 2 | 2021 | 69 | 0.320 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2017 | 4026 | 0.280 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3802 | 0.280 |
Why?
|
| Nuclear Proteins | 2 | 2019 | 5796 | 0.280 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 2895 | 0.280 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 3617 | 0.210 |
Why?
|
| Laryngeal Neoplasms | 2 | 2017 | 514 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 4 | 2021 | 5789 | 0.200 |
Why?
|
| Reed-Sternberg Cells | 1 | 2021 | 72 | 0.180 |
Why?
|
| Sezary Syndrome | 1 | 2020 | 80 | 0.170 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 587 | 0.160 |
Why?
|
| Transcription Factors | 1 | 2019 | 12128 | 0.160 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 16981 | 0.160 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2023 | 1374 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2023 | 8547 | 0.150 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2017 | 18 | 0.140 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2017 | 57 | 0.140 |
Why?
|
| Lymphoma, B-Cell | 1 | 2023 | 940 | 0.130 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2015 | 89 | 0.130 |
Why?
|
| CpG Islands | 1 | 2020 | 1230 | 0.130 |
Why?
|
| Genetics, Population | 1 | 2020 | 937 | 0.130 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1405 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2020 | 2919 | 0.110 |
Why?
|
| Heterozygote | 1 | 2019 | 2787 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4278 | 0.090 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2017 | 946 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1974 | 0.080 |
Why?
|
| Placenta | 1 | 2017 | 1709 | 0.070 |
Why?
|
| Biopsy | 1 | 2019 | 6766 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7594 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2021 | 519 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 4758 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11076 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10445 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12795 | 0.060 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2023 | 87 | 0.060 |
Why?
|
| Transcription Factor TFIIH | 1 | 2023 | 30 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7856 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9420 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 11903 | 0.050 |
Why?
|
| Proteins | 1 | 2017 | 6032 | 0.050 |
Why?
|
| Humans | 12 | 2023 | 761504 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2023 | 545 | 0.040 |
Why?
|
| Germinal Center | 1 | 2023 | 380 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2023 | 589 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2023 | 569 | 0.040 |
Why?
|
| Mycosis Fungoides | 1 | 2020 | 170 | 0.040 |
Why?
|
| Mutation | 2 | 2021 | 30052 | 0.040 |
Why?
|
| Cell Line | 2 | 2023 | 15601 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2021 | 1217 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 8540 | 0.030 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 382 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 1084 | 0.030 |
Why?
|
| China | 1 | 2020 | 2369 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2017 | 749 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3422 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1844 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2017 | 646 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2021 | 2909 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2017 | 518 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2020 | 3395 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1896 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3778 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8320 | 0.020 |
Why?
|
| Computational Biology | 1 | 2015 | 3518 | 0.010 |
Why?
|
| Female | 5 | 2021 | 392644 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11121 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 169289 | 0.010 |
Why?
|
| Male | 4 | 2021 | 360804 | 0.010 |
Why?
|
| Middle Aged | 3 | 2021 | 220895 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23445 | 0.010 |
Why?
|
| Adult | 3 | 2020 | 221177 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81525 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 58976 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 29874 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 168459 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59243 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 88319 | 0.000 |
Why?
|